Follow-up of the effect of BCG in bladder tumour patients.

P. Tenke, S. Csata, G. Kulcsár

Research output: Contribution to journalArticle

Abstract

The intravesical BCG effect in 38 patients with superficial bladder tumour after TUR was followed by the lymphocyte transformation test (LTT) and the staphylococcus phagocytosis test of in vitro washed leukocytes. The results have confirmed the immunostimulating and hence anti-tumour effect of intravesical BCG. The beginning and the duration of the stimulation effect were defined and the necessity of maintenance treatment was verified. Authors consider monitoring of the cellular immune response suitable for the continuous follow-up of the BCG effect. Comparing the tolerable side-effects with their favourable therapeutic results, BCG is considered to be suitable for the prevention of recurrences in treating superficial bladder tumours.

Original languageEnglish
Pages (from-to)131-139
Number of pages9
JournalActa Chirurgica Hungarica
Volume32
Issue number2
Publication statusPublished - 1991

Fingerprint

Mycobacterium bovis
Urinary Bladder Neoplasms
Lymphocyte Activation
Staphylococcus
Phagocytosis
Cellular Immunity
Leukocytes
Recurrence
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Follow-up of the effect of BCG in bladder tumour patients. / Tenke, P.; Csata, S.; Kulcsár, G.

In: Acta Chirurgica Hungarica, Vol. 32, No. 2, 1991, p. 131-139.

Research output: Contribution to journalArticle

Tenke, P, Csata, S & Kulcsár, G 1991, 'Follow-up of the effect of BCG in bladder tumour patients.', Acta Chirurgica Hungarica, vol. 32, no. 2, pp. 131-139.
Tenke, P. ; Csata, S. ; Kulcsár, G. / Follow-up of the effect of BCG in bladder tumour patients. In: Acta Chirurgica Hungarica. 1991 ; Vol. 32, No. 2. pp. 131-139.
@article{32b218e93cae4f58a7b3bed00372344d,
title = "Follow-up of the effect of BCG in bladder tumour patients.",
abstract = "The intravesical BCG effect in 38 patients with superficial bladder tumour after TUR was followed by the lymphocyte transformation test (LTT) and the staphylococcus phagocytosis test of in vitro washed leukocytes. The results have confirmed the immunostimulating and hence anti-tumour effect of intravesical BCG. The beginning and the duration of the stimulation effect were defined and the necessity of maintenance treatment was verified. Authors consider monitoring of the cellular immune response suitable for the continuous follow-up of the BCG effect. Comparing the tolerable side-effects with their favourable therapeutic results, BCG is considered to be suitable for the prevention of recurrences in treating superficial bladder tumours.",
author = "P. Tenke and S. Csata and G. Kulcs{\'a}r",
year = "1991",
language = "English",
volume = "32",
pages = "131--139",
journal = "Magyar Sebeszet",
issn = "0025-0295",
publisher = "Ifjusagi Lapkiado Vallalat",
number = "2",

}

TY - JOUR

T1 - Follow-up of the effect of BCG in bladder tumour patients.

AU - Tenke, P.

AU - Csata, S.

AU - Kulcsár, G.

PY - 1991

Y1 - 1991

N2 - The intravesical BCG effect in 38 patients with superficial bladder tumour after TUR was followed by the lymphocyte transformation test (LTT) and the staphylococcus phagocytosis test of in vitro washed leukocytes. The results have confirmed the immunostimulating and hence anti-tumour effect of intravesical BCG. The beginning and the duration of the stimulation effect were defined and the necessity of maintenance treatment was verified. Authors consider monitoring of the cellular immune response suitable for the continuous follow-up of the BCG effect. Comparing the tolerable side-effects with their favourable therapeutic results, BCG is considered to be suitable for the prevention of recurrences in treating superficial bladder tumours.

AB - The intravesical BCG effect in 38 patients with superficial bladder tumour after TUR was followed by the lymphocyte transformation test (LTT) and the staphylococcus phagocytosis test of in vitro washed leukocytes. The results have confirmed the immunostimulating and hence anti-tumour effect of intravesical BCG. The beginning and the duration of the stimulation effect were defined and the necessity of maintenance treatment was verified. Authors consider monitoring of the cellular immune response suitable for the continuous follow-up of the BCG effect. Comparing the tolerable side-effects with their favourable therapeutic results, BCG is considered to be suitable for the prevention of recurrences in treating superficial bladder tumours.

UR - http://www.scopus.com/inward/record.url?scp=0026298448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026298448&partnerID=8YFLogxK

M3 - Article

C2 - 1819883

AN - SCOPUS:0026298448

VL - 32

SP - 131

EP - 139

JO - Magyar Sebeszet

JF - Magyar Sebeszet

SN - 0025-0295

IS - 2

ER -